UNSPSC 51101652: Difetarsone

This classification denotes an antiprotozoal agent with the molecular formula C14H18As2N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G4G9J3Q65W, chemically known as n,n-ethylenediarsanilic acid but generally known as difetarsone, which bears US NIH Compound Identifier 68199. European Medicines Agency schedules Difetarsone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07124MIG.

UNSPSC 51101652 Difetarsone, a Commodity code, does not reflect the work actually being solicited under recent state and local opportunities posted against this classification. The code nominally identifies a specific pharmaceutical compound, but recent state and local procurement activity tagged to this code encompasses a much broader range of pharmaceutical products, medical supplies, and health-related procurement — including naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, direct-to-manufacturer prescription programs, and medical and first aid supplies for emergency response. Issuing bodies posting opportunities under this code include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), municipal fire and rescue divisions (City of Tampa), and cooperative purchasing alliances serving multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance). The mismatch between the code's nominal scope and the actual procurement activity suggests either miscoding at the source or a data-quality issue in how state and local procurement offices are tagging pharmaceutical and medical supply solicitations.

The most recent activity spans Florida, Texas, Minnesota, and Oregon, with the most concrete recent opportunity being the City of Tampa's IFB 26P00145 for medical and first aid supplies to the Tampa Fire Department Rescue Division, due March 13, 2026, with an estimated contract amount of $700,000 and a Small Local Business Enterprise set-aside with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, awarding through authorized wholesalers with effectiveness July 1, 2026. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, though the posted due date of July 26, 2023 is inconsistent with the June 2026 posting date. The Texas HHS Commission issued RFI HHS0017013 in March 2026 as exploratory market intelligence for a direct-to-manufacturer prescription program, with response deadline April 3, 2026. Given the code-scope mismatch and limited volume of recent opportunities, treat this code as showing minimal relevant activity for targeted pursuit.